The Decentralised procedure used for the registration of ROVIs biosimilar of enoxaparin has been completed with positive outcome.


No votes yet
 
Related
Operating income, growth figures, profitability and how our products have behaved.
1 min
20/02/2018
0 min
21/12/2017